Cannabinol-C4

Cannabinol-C4

Cannabinol-C4 (CBN-C4) is a minor cannabinoid found in the Cannabis plant. It is a homolog of cannabinol (CBN), differing by the length of its alkyl side chain. While CBN has a pentyl (C5) side chain, CBN-C4 has a butyl (C4) side chain. This structural difference can influence the compound's pharmacological properties and its interaction with the endocannabinoid system.

Chemical Structure and Properties

Cannabinol-C4 is chemically similar to CBN, with the primary difference being the length of the alkyl side chain. The molecular formula of CBN-C4 is C20H24O2, and it has a molecular weight of 296.41 g/mol. The presence of a butyl side chain instead of a pentyl side chain may affect its binding affinity to cannabinoid receptors.

Pharmacology

CBN-C4, like other cannabinoids, interacts with the endocannabinoid system, which includes the CB1 and CB2 receptors. However, due to its structural differences, CBN-C4 may have a different binding affinity and efficacy compared to CBN. Research on CBN-C4 is limited, but it is believed to have potential therapeutic effects similar to other cannabinoids, such as anti-inflammatory and analgesic properties.

Potential Therapeutic Uses

While research is still in its early stages, CBN-C4 may have potential therapeutic applications. Cannabinoids are known for their diverse effects, including pain relief, anti-inflammatory effects, and neuroprotection. CBN-C4 could potentially be used in the treatment of conditions such as chronic pain, inflammation, and possibly neurodegenerative diseases.

Research and Development

The study of minor cannabinoids like CBN-C4 is an emerging field. As the legal landscape surrounding cannabis research evolves, more studies are being conducted to explore the unique properties and potential benefits of these compounds. Understanding the specific effects of CBN-C4 could lead to the development of new therapeutic agents.

Also see

• Cannabinoid
• Cannabinol
• Endocannabinoid system
• CB1 receptor
• CB2 receptor